Publications
- Novel Treatment Options in Metastatic Esophageal Carcinoma: Checkpoint Inhibitors in Combination Therapies2023 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- A novel anti-CD47-targeted blockade promotes immune activation in human soft tissue sarcoma but does not potentiate anti-PD-1 blockade2023 | Second Faculty of Medicine, First Faculty of Medicine
- Current treatment options for monogenic periodic fever syndromes - the role of interleukin 1 inhibitors2022 | Second Faculty of Medicine, Central Library of Charles University
- The Immune Contexture of Liposarcoma and Its Clinical Implications2022 | Second Faculty of Medicine, First Faculty of Medicine
- The Periphery of Salivary Gland Carcinoma Tumors Reveals a PD-L1/PD-1 Biomarker Niche for the Evaluation of Disease Severity and Tumor-Immune System Interplay2021 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?2021 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives2021 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Fas-Fas Ligand Interplay in the Periphery of Salivary Gland Carcinomas as a New Checkpoint Predictor for Disease Severity and Immunotherapy Response2021 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Novel insights into the immunotherapy of soft tissue sarcomas: Do we need a change of perspective?2021 | Second Faculty of Medicine, First Faculty of Medicine
- Novel therapeutic approaches in the treatment of solitary fibrous tumors: A call for a combination therapy2020 | Second Faculty of Medicine, First Faculty of Medicine
Loading network view...
